Acute haemodynamics and gas exchange of CTEPH and pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
LATE-BREAKING ABSTRACT: Pulmonary gas exchange differentiates pulmonary arterial from venous hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013
Contrasting physiological responses to the six minute walk test in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH) Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Gas exchange impairment in COPD with severe pulmonary hypertension Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021
Effect of pulmonary hypertension on gas exchange in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003
Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015
Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007
Gas transfer measurement in systemic sclerosis associated pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension with ventilatory gas analysis Source: International Congress 2016 – Acute pulmonary embolism Year: 2016
Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Insights into ventilation–gas exchange coupling in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2016; 48: 252-254 Year: 2016
Pregnancy and pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009
Iron deficiency in pulmonary arterial hypertension: A matter of definition! Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Role of arterial blood gases, continuous positive airway pressure and ddimers to rule out pulmonary embolism suspected in obese patients Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Effects of amlodipine on pulmonary haemodynamics in pulmonary hypertension (PH) secondary to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002
Pulmonary capillary recruitment in exercise and pulmonary hypertension Source: Eur Respir J, 51 (3) 1800260; 10.1183/13993003.00260-2018 Year: 2018
Pulmonary capillary recruitment in exercise and pulmonary hypertension Source: Eur Respir J, 51 (3) 1702559; 10.1183/13993003.02559-2017 Year: 2018
Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015
Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017